|
Patients’ eligibility for liver transplantation may be lowered by …
News-Medical.net Results from an anonymous survey of U.S. transplant providers report that incarceration, marijuana use, and psychiatric diagnoses, particularly suicide attempts, may lower patients’ eligibility for liver transplantation. The study published in the … |
Rose-Leigh readies for stem cells – Independent Online
|
Rose-Leigh readies for stem cells
Independent Online Rose-Leigh’s family and doctor hope the stem cell transplant will give her a new lease on life. The little girl has a generally incurable form of lymphoma, with the longest survival rate being 16 months after detection and most patients dying from the … |
Rapid, scalable and highly automated HLA genotyping using next-generation … – 7thSpace Interactive (press release)
Rapid, scalable and highly automated HLA genotyping using next-generation …7thSpace Interactive (press release)Thus, next-generation sequencing is entering into diagnostic laboratories at the perfect time and serving as a promising tool to overcome i…
Multiple Sklerose: Daclizumab HYP halbiert Schubfrequenz – Deutsches Ärzteblatt
 Hannover Zeitung |
Multiple Sklerose: Daclizumab HYP halbiert Schubfrequenz
Deutsches Ärzteblatt Bochum – Der monoklonale Antikörper Daclizumab HYP, eine Variante des 1999 zur Prophylaxe akuter Abstoßungsreaktionen nach Nierentransplantation eingeführten Immunsuppressivums Daclizumab, hat in einer Phase-II-Studie vielversprechende … Multiple Sklerose: Daclizumab HYP halbiert die Wahrscheinlichkeit von SchübenInformationsdienst Wissenschaft (Pressemitteilung) Vielversprechender neuer Wirkstoff gegen Multiple SklerosederStandard.at |
Lancet Publishes SELECT Study of Biogen's Daclizumab HYP, Biogen Says … – Benzinga
|
Lancet Publishes SELECT Study of Biogen’s Daclizumab HYP, Biogen Says …
Benzinga Today Biogen Idec (NASDAQ: BIIB) announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an online article in The Lancet. SELECT was a Phase 2b study designed to determine the efficacy … Market opening: Biogen Idec up after positive MS drug studyMarketWatch (blog) |
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of … – Financial Post
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of …Financial PostToday Biogen Idec (NASDAQ: BIIB) announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an online article…
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of … – MarketWatch (press release)
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of …MarketWatch (press release)Today Biogen Idec (NASDAQ:BIIB) announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an on…
Siberian scientists test anti-ageing pills on themselves – Russia & India Report
|
Siberian scientists test anti-ageing pills on themselves
Russia & India Report Siberian scientists have tested newly-developed drugs for the treatment of liver cirrhosis – more widely known as ‘anti-ageing pills’ – on themselves, without waiting for the results of clinical trials. The developers said they’d noticed very positive … |
National Cancer Institution: Major steps taken on breast cancer and leukemia – Ahram Online
 Ahram Online |
National Cancer Institution: Major steps taken on breast cancer and leukemia
Ahram Online Kamal then moved on to explain that before 2000 there was no medication and the only option was a risky stem cell transplant. After 2000, came two generations of “targeted medication” — the first being a ray of hope, the second the chance of a cure. |
Rahul's speech impressive, he spoke from heart: India Inc – Zee News
 Zee News |
Rahul’s speech impressive, he spoke from heart: India Inc
Zee News Sam Pitroda, adviser to Prime Minister, also said, “I liked it. I think he spoke from his heart. He talked about inclusive growth and collaboration. I have worked with him. We have a very long relationship with Rajiv Gandhi and the family, and with … |